“…Most trials on hydrogels for the treatment of cancer have investigated the injection of hydrogels into mice [ 22 , 23 , 24 ]. A series of injectable and cross-linked hydrogels using biocompatible and carbohydrate-based polymers such as quaternized chitosan, hyaluronic acid, fucoidan, and poly-ethylene glycol have been developed as nanocarriers for the delivery of therapeutic agents [ 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]. However, hydrogels remain in the injection site for a certain period of time, which may promote inflammation and other side effects [ 33 , 34 ].…”